Results 161 to 170 of about 15,050 (215)

Comparison of Neovascular Age-Related Macular Degeneration Outcomes in Established vs New Patients of a Retina Practice. [PDF]

J Vitreoretin Dis
Du J, Chen MY, Dasan R, Chen A, Kim G, Naidu A, Ebert J, Huang JM, Levinson JD, Ali MH, Do BK.   +10 more
europepmc   +1 more source

Faricimab for Refractory Neovascular Age-Related Macular Degeneration: Retrospective Real-World Evidence from India. [PDF]

Clin Ophthalmol
Biswas RK, Sheth JU, Shrivastava V, Kaur J, Sinha S, Pal SS, Nandi K, Das S.   +7 more
europepmc   +1 more source

A prospective, open-label, single-arm, investigator-initiated clinical trial to assess the efficacy, safety and durability of faricimab in patients with inadequate response to current treatment for neovascular age-related macular degeneration: protocol design and rationale for the FURGGHORN Study. [PDF]

BMJ Open Ophthalmol
Phan LT, Hong T, Chang JH, Mehta H, Fraser-Bell S, Cheung GCM, Broadhead GK, Chang AA.   +7 more
europepmc   +1 more source

Network Meta-Analysis of Bevacizumab Gamma Versus Competing Interventions for Treating Neovascular Age-Related Macular Degeneration in the United Kingdom. [PDF]

J Mark Access Health Policy
Lorenzi M, Ebohon S, Kissner J, Comiskey J, Paap M, Bouchet C, Garnham A, Wissinger E.   +7 more
europepmc   +1 more source

Gentherapie zur Behandlung der nAMD: das TargetAMD-Projekt

, 2016
Kropp, Martina, Thumann, Gabriele
openaire   +1 more source

Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration: XTEND at 3 Years.

Ophthalmologica
Korobelnik JF, Chaudhary V, Mitchell P, Kang SW, Allmeier H, Lee J, Zhang X, Machewitz T, Bailey C.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pouring SIRAH on NAMD.

The Journal of Physical Chemistry B
Molecular dynamics (MD) simulations provide an invaluable platform for exploring the dynamics of complex biomolecular systems at atomic resolution. However, compatibility issues between force fields and MD software engines can limit the interoperability ...
J. Cantero, Andrés Ballesteros-Casallas, L. S. Santos, Margot Paulino, Sergio Pantano   +4 more
semanticscholar   +3 more sources

Efficacy of treatment with faricimab for patients with refractory nAMD

European Journal of Ophthalmology
Objective To investigate the efficacy of treatment with faricimab in patients with refractory neovascular age-related macular degeneration (nAMD). Methods A Single-centre, retrospective cohort study was conducted on patients treated with faricimab for ...
Nabila Jones, Christa Gore, Habiba Saedon, Clare O'Donnell, Sajjad Mahmood   +4 more
semanticscholar   +3 more sources

Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis

Eye, 2022
Amirthan Sothivannan, Gurkaran S Sarohia, Sobha Sivaprasad   +2 more
exaly   +2 more sources